Award of NHS Framework Agreements for Branded Medicines (Tranche A London & South of England and Adult Influenza National)

About

NHS England awarded a contract to Roche Products Ltd, Amgen Ltd, Seqirus UK Limited, Biogen, Teva UK Limited, Dr.

Reddy's Laboratories (UK) Limited, Orifarm UK, Pfizer Ltd, Vifor Pharma UK Ltd, Accord-UK Ltd, Sandoz Ltd, Eli Lilly & Company Ltd, and others for NHS Framework Agreements for Branded Medicines.

The agreement covers Tranche A for London and South of England, effective 01 September 2025 to 31 August 2027 with an option to extend up to 24 months, and Adult Influenza (National), effective 01 September 2025 to 31 August 2026 with an option to extend up to 36 months.

The total contract value is £261,895,933.